Biblio

Export 1170 results:
Author Title [ Type(Asc)] Year
Filters: First Letter Of Last Name is R  [Clear All Filters]
Journal Article
H. Lukkarinen, Tesseur, I., Pemberton, D., van der Ark, P., Timmers, M., Slemmon, R., Janssens, L., Streffer, J., Van Nueten, L., Bottelbergs, A., Rauramaa, T., Koivisto, A. M., Herukka, S. - K., Korhonen, V. E., Junkkari, A., Hiltunen, M., Engelborghs, S., Blennow, K., Zetterberg, H., Kolb, H. C., and Leinonen, V., “Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.”, J Alzheimers Dis, vol. 80, no. 4, pp. 1629-1642, 2021.
H. V. Rao, Bihaqi, S. W., Iannucci, J., Sen, A., and Grammas, P., “Thrombin Signaling Contributes to High Glucose-Induced Injury of Human Brain Microvascular Endothelial Cells.”, J Alzheimers Dis, vol. 79, no. 1, pp. 211-224, 2021.
E. Guzmán-Vélez, Jaimes, S., Aguirre-Acevedo, D. C., Norton, D. J., Papp, K. V., Amariglio, R., Rentz, D., Baena, A., Henao, E., Tirado, V., Munoz, C., Giraldo, M., Sperling, R. A., Lopera, F., and Quiroz, Y. T., “A Three-Factor Structure of Cognitive Functioning Among Unimpaired Carriers and Non-Carriers of Autosomal-Dominant Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 1, pp. 107-115, 2018.
T. Hang Wong, Pottier, C., Hondius, D. C., Meeter, L. H. H., van Rooij, J. G. J., Melhem, S., van Minkelen, R., van Duijn, C. M., Rozemuller, A. J. M., Seelaar, H., Rademakers, R., and van Swieten, J. C., “Three VCP Mutations in Patients with Frontotemporal Dementia.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1139-1146, 2018.
T. Hang Wong, Pottier, C., Hondius, D. C., Meeter, L. H. H., van Rooij, J. G. J., Melhem, S., van Minkelen, R., van Duijn, C. M., Rozemuller, A. J. M., Seelaar, H., Rademakers, R., and van Swieten, J. C., “Three VCP Mutations in Patients with Frontotemporal Dementia.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1139-1146, 2018.
D. Angulo Sevilla, Rodríguez, M. Teresa Car, Rodríguez, P. Heredia, Sánchez, M. Fernández, Mora, J. Aurelio Vi, and Gago-Veiga, A. Beatriz, “Is There a Characteristic Clinical Profile for Patients with Dementia and Sundown Syndrome?”, J Alzheimers Dis, vol. 62, no. 1, pp. 335-346, 2018.
D. Angulo Sevilla, Rodríguez, M. Teresa Car, Rodríguez, P. Heredia, Sánchez, M. Fernández, Mora, J. Aurelio Vi, and Gago-Veiga, A. Beatriz, “Is There a Characteristic Clinical Profile for Patients with Dementia and Sundown Syndrome?”, J Alzheimers Dis, vol. 62, no. 1, pp. 335-346, 2018.
R. Kandimalla and P Reddy, H., “Therapeutics of Neurotransmitters in Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1049-1069, 2017.
J. Mendiola-Precoma, Padilla, K., Rodríguez-Cruz, A., Berumen, L. C., Miledi, R., and García-Alcocer, G., “Theobromine-Induced Changes in A1 Purinergic Receptor Gene Expression and Distribution in a Rat Brain Alzheimer's Disease Model.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1273-1283, 2017.
V. Shukla, Seo, J., Binukumar, B. K., Amin, N. D., Reddy, P., Grant, P., Kuntz, S., Kesavapany, S., Steiner, J., Mishra, S. K., Tsai, L. - H., and Pant, H. C., “TFP5, a Peptide Inhibitor of Aberrant and Hyperactive Cdk5/p25, Attenuates Pathological Phenotypes and Restores Synaptic Function in CK-p25Tg Mice.”, J Alzheimers Dis, vol. 56, no. 1, pp. 335-349, 2017.
C. Bussè, Caffarra, P., Rossi, A., Zorzi, G., Fragiacomo, F., Camporese, G., Pompanin, S., Di Bernardo, G. Antonio, and Cagnin, A., “Testing Hippocampal Memory in Prodromal Dementia with Lewy Bodies.”, J Alzheimers Dis, vol. 64, no. 2, pp. 349-353, 2018.
G. W. Rebok, Ball, K., Guey, L. T., Jones, R. N., Kim, H. - Y., King, J. W., Marsiske, M., Morris, J. N., Tennstedt, S. L., Unverzagt, F. W., and Willis, S. L., “Ten-year effects of the advanced cognitive training for independent and vital elderly cognitive training trial on cognition and everyday functioning in older adults.”, J Am Geriatr Soc, vol. 62, no. 1, pp. 16-24, 2014.
M. Bilgel, Koscik, R. L., An, Y., Prince, J. L., Resnick, S. M., Johnson, S. C., and Jedynak, B. M., “Temporal Order of Alzheimer's Disease-Related Cognitive Marker Changes in BLSA and WRAP Longitudinal Studies.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1335-1347, 2017.
K. N. H. Nudelman, Lin, J., Lane, K. A., Nho, K., Kim, S., Faber, K. M., Risacher, S. L., Foroud, T. M., Gao, S., Davis, J. W., Weiner, M. W., and Saykin, A. J., “Telomere Shortening in the Alzheimer's Disease Neuroimaging Initiative Cohort.”, J Alzheimers Dis, vol. 71, no. 1, pp. 33-43, 2019.
E. Z. Huie, Escudero, A., Saito, N., Harvey, D., Le Nguyen, M. -, Lucot, K. L., LaGrande, J., Mungas, D., DeCarli, C., Lamar, M., Schneider, J. A., Kapasi, A., Rissman, R. A., Teich, A. F., and Dugger, B. N., “TDP-43 Pathology in the Setting of Intermediate and High Alzheimer's Disease Neuropathologic Changes: A Preliminary Evaluation Across Ethnoracial Groups.”, J Alzheimers Dis, vol. 91, no. 4, pp. 1291-1301, 2023.
B. H Kuiperij, Versleijen, A. A. M., Beenes, M., Verwey, N. A., Benussi, L., Paterlini, A., Binetti, G., Teunissen, C. E., Raaphorst, J., Schelhaas, H. J., Küsters, B., Pijnenburg, Y. A. L., Ghidoni, R., and Verbeek, M. M., “Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot Study.”, J Alzheimers Dis, vol. 55, no. 2, pp. 585-595, 2017.
A. Slachevsky, Guzmán-Martínez, L., Delgado, C., Reyes, P., Farías, G. A., Muñoz-Neira, C., Bravo, E., Farías, M., Flores, P., Garrido, C., Becker, J. T., Lopez, O. L., and Maccioni, R. B., “Tau Platelets Correlate with Regional Brain Atrophy in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1595-1603, 2017.
M. Kolarova, Sengupta, U., Bartos, A., Ricny, J., and Kayed, R., “Tau Oligomers in Sera of Patients with Alzheimer's Disease and Aged Controls.”, J Alzheimers Dis, vol. 58, no. 2, pp. 471-478, 2017.
C. M. Roe, Babulal, G. M., Mishra, S., Gordon, B. A., Stout, S. H., Ott, B. R., Carr, D. B., Ances, B. M., Morris, J. C., and Benzinger, T. L. S., “Tau and Amyloid Positron Emission Tomography Imaging Predict Driving Performance Among Older Adults with and without Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 2, pp. 509-513, 2018.
C. Hyoung Lyoo, Cho, H., Choi, J. Yong, Hwang, M. Song, Hong, S. Kyoon, Kim, Y. Joong, Ryu, Y. Hoon, and Lee, M. Sik, “Tau Accumulation in Primary Motor Cortex of Variant Alzheimer's Disease with Spastic Paraparesis.”, J Alzheimers Dis, vol. 51, no. 3, pp. 671-5, 2016.
S. Gauthier, Ng, K. Pin, Pascoal, T. A., Zhang, H., and Rosa-Neto, P., “Targeting Alzheimer's Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment.”, J Alzheimers Dis, vol. 64, no. s1, pp. S23-S31, 2018.
M. Buciuc, Tosakulwong, N., Machulda, M. M., Whitwell, J. L., Weigand, S. D., Murray, M. E., R Reichard, R., Parisi, J. E., Dickson, D. W., Boeve, B. F., Knopman, D. S., Petersen, R. C., and Josephs, K. A., “TAR DNA-Binding Protein 43 Is Associated with Rate of Memory and Functional and Global Cognitive Decline in the Decade Prior to Death.”, J Alzheimers Dis, vol. 80, no. 2, pp. 683-693, 2021.
D. Gouilly, Tisserand, C., Nogueira, L., Saint-Lary, L., Rousseau, V., Benaiteau, M., Rafiq, M., Carlier, J., Milongo-Rigal, E., Pagès, J. - C., and Pariente, J., “Taking the A Train? Limited Consistency of Aβ42 and the Aβ42/40 Ratio in the AT(N) Classification.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1033-1038, 2021.
D. Gouilly, Tisserand, C., Nogueira, L., Saint-Lary, L., Rousseau, V., Benaiteau, M., Rafiq, M., Carlier, J., Milongo-Rigal, E., Pagès, J. - C., and Pariente, J., “Taking the A Train? Limited Consistency of Aβ42 and the Aβ42/40 Ratio in the AT(N) Classification.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1033-1038, 2021.
A. Bahar-Fuchs, Webb, S., Bartsch, L., Clare, L., Rebok, G., Cherbuin, N., and Anstey, K. J., “Tailored and Adaptive Computerized Cognitive Training in Older Adults at Risk for Dementia: A Randomized Controlled Trial.”, J Alzheimers Dis, vol. 60, no. 3, pp. 889-911, 2017.

Pages